Background: This study aimed to identify the clinical signs and symptoms most associated with fatal outcomes in Ebola virus disease (EVD) using a Bayesian framework.
Aim: The goal was to develop a prognostic model capable of predicting mortality in EVD patients treated in Ebola Treatment Centres (ETCs) based on observed clinical indicators.
Setting: A retrospective expert-based study of the 10th Ebola outbreak was conducted to identify key mortality factors using hypothetical cases in the Democratic Republic of the Congo.
Methods: Clinical experts assessed mortality predictors in Ebola cases using Bayesian methods to estimate likelihood ratios and post-test probabilities, with analyses conducted in Excel and SPSS.
Results: Eight clinical factors were identified as potential predictors of poor outcomes in Ebola virus disease. Five showed strong associations with mortality: deterioration in general condition and comorbidity, hemorrhagic syndrome, neurological disorders, biological deterioration with dehydration, and high viral load at diagnosis. Internal validation using 42 hypothetical cases demonstrated excellent performance (sensitivity [Se] = 97.4%, specificity [Sp] = 100.0%, positive predictive value [PPV] = 100.0%, negative predictive value [NPV] = 75.0%, accuracy = 97.6%) and strong expert agreement (κ = 0.84).
Conclusion: The model demonstrated strong internal validity in predicting mortality from Ebola virus disease. Among five key predictors, bleeding syndrome, neurological disorders, and biological alteration with dehydration were the most accurate, each correctly predicting fatal outcomes in 83% of cases.
Contribution: This Bayesian model offers a useful decision-support tool for managing Ebola outbreaks.
Keywords: Ebola; fatality; internal; subjective Bayes model; validation.
© 2025. The Authors.